Active specific immunotherapy of minimal residual tumor: Excision plus neuraminidase-treated tumor cells-Reference-Cited by-同舟云学术

Active specific immunotherapy of minimal residual tumor: Excision plus neuraminidase-treated tumor cells

Published:1974-01-15 Issue:1 Volume:13 Page:71-81
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Rios Angelyn,Simmons Richard L.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference22 articles.

1. Immunogenicity of L 1210 Murine Leukaemia Cells after Treatment with Neuraminidase

2. , and , VI. Cytotoxic test for demonstration of mouse antibody. In: (ed.), Methods in medical research, Vol. 10, p. 39–47, Year Book Medical Publishers, Inc., Chicago (1964).

3. The role of sialic acid in antigenic expression: further studies of the Landschütz ascites tumour

4. Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into the Role of Sialylation in Cancer Metastasis, Immunity, and Therapeutic Opportunity;Cancers;2022-11-26

2. Chemical xenogenization of experimental tumors;Cancer and Metastasis Reviews;1987-06

3. Tumor therapy of neoplastic diseases with tumor cells and neuraminidase: Experimental studies on chessboard vaccination in transplantation tumors;International Journal of Immunopharmacology;1987-01

4. Immunology and Oncology;International Review of Cytology;1985

5. Cyclophosphamide-mediated enhancement of antitumor immune potential of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumor;International Journal of Immunopharmacology;1985-01